Nannan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nannan Zhang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Fangzhen Shan
Medical Research Centre, Affiliated Hospital of Jining Medical University, Jining, China
3 shared publications Fangzhen Shan
Medical Research Center Affiliated Hospital of Jining Medical University Shandong China
2 shared publicationsWei Wu
Department of Pulmonary and Critical Care Medicine Affiliated Hospital of Jining Medical University Shandong China
2 shared publications- Yuzhong Wang
Department of Neurology Affiliated Hospital of Jining Medical University Jining China
2 shared publications Bangdong Liu
Department of Pathology Affiliated Hospital of Jining Medical University Shandong China
1 shared publicationFang-Zhen Shan
Medical Research Center, Affiliated Hospital of Jining Medical University, Jining, 272029, Shandong, China; Hefei National Laboratory for Physical Science at Microscale and School of Life Science, University of Science and Technology of China, Hefei, 230026, Anhui, China
1 shared publication
Latest Publications
- Open Access
- 24 January 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Pulmonary Nocardia otitidiscaviarum in immunocompetent individuals: a case series and literature review
Nocardia are filamentous, Gram-positive, aerobic bacteria widely distributed in diverse environments. Nocardia otitidiscaviarum, first isolated from the mi
- 24 January 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessPulmonary Nocardia otitidiscaviarum in immunocompetent individuals: a case series and literature review
Nocardia are filamentous, Gram-positive, aerobic bacteria widely distributed in diverse environments. Nocardia otitidiscaviarum, first isolated from the mi
- Open Access
- 23 January 2026
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 20 (1) , e70168
SMARCA4‐Deficient Undifferentiated Thoracic Tumor: Clinical Features and Prognosis of a Case Series and Literature Review
Introduction: Thoracic SMARCA4‐deficient undifferentiated tumors (SMARCA4‐UT) are rare and aggressive epithelioid neoplasms characterized by the loss of the SMARCA4 gene. These tumors are typically diagnosed at advanced stages and exhibit a dismal prognosis. Currently, there are no standardized treatment protocols or approved targeted therapies. Methods: We present a case series of nine patients diagnosed of thoracic SMARCA4‐UT, detailing demographic, pathological, imaging, and treatment data. Moreover, a comprehensive literature review and genomic analysis of SMARCA4 mutations in lung cancer were also performed. Results: The cohort comprised predominantly male smokers (mean age: 63.0 ± 9.6 years). All cases exhibited loss of BRG1 expression, with negative staining for TTF‐1 and p40, while SMARCB1/INI‐1 expression was preserved. Patients showed poor responses to conventional chemotherapy but demonstrated partial responsiveness to immunotherapy or targeted agents. Genomic analysis of SMARCA4 mutations in lung cancer demonstrates that SMARCA4 mutations, primarily located in the SNF2‐related and helicase conserved C‐terminal domains, are associated with a poorer prognosis in lung cancer. Conclusion: Immunotherapy and targeted therapies show promise in managing thoracic SMARCA4‐UT, warranting further investigation. Further exploring the genetic and molecular landscape of this tumor might reveal potential therapeutic targets.
- 23 January 2026
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 20 (1) , e70168
Open AccessSMARCA4‐Deficient Undifferentiated Thoracic Tumor: Clinical Features and Prognosis of a Case Series and Literature Review
Introduction: Thoracic SMARCA4‐deficient undifferentiated tumors (SMARCA4‐UT) are rare and aggressive epithelioid neoplasms characterized by the loss of the SMARCA4 gene. These tumors are typically diagnosed at advanced stages and exhibit a dismal prognosis. Currently, there are no standardized treatment protocols or approved targeted therapies. Methods: We present a case series of nine patients diagnosed of thoracic SMARCA4‐UT, detailing demographic, pathological, imaging, and treatment data. Moreover, a comprehensive literature review and genomic analysis of SMARCA4 mutations in lung cancer were also performed. Results: The cohort comprised predominantly male smokers (mean age: 63.0 ± 9.6 years). All cases exhibited loss of BRG1 expression, with negative staining for TTF‐1 and p40, while SMARCB1/INI‐1 expression was preserved. Patients showed poor responses to conventional chemotherapy but demonstrated partial responsiveness to immunotherapy or targeted agents. Genomic analysis of SMARCA4 mutations in lung cancer demonstrates that SMARCA4 mutations, primarily located in the SNF2‐related and helicase conserved C‐terminal domains, are associated with a poorer prognosis in lung cancer. Conclusion: Immunotherapy and targeted therapies show promise in managing thoracic SMARCA4‐UT, warranting further investigation. Further exploring the genetic and molecular landscape of this tumor might reveal potential therapeutic targets.
- Open Access
- 16 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8
NMDA Receptors Coordinate Metabolic Reprogramming and Mitophagy in Schwann Cells to Promote Peripheral Nerve Regeneration
Schwann cells (SCs) are indispensable for peripheral nerve regeneration, yet the mechanisms enabling their metabolic adaptation to meet the energetic demands of axonal repair remain elusive. Here, we identify N-methyl-D-aspartate (NMDA) receptors as central regulators of SC metabolic plasticity. In a mouse model of acute motor axonal neuropathy, nerve injury led to a marked decrease in NMDA receptor expression on SC. Functional studies revealed that NMDA receptors mediate calcium influx to drive glycolysis and oxidative phosphorylation via the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin and hypoxia-inducible factor-1α/c-Myc pathways, ensuring adenosine triphosphate production for axonal repair. Simultaneously, NMDA receptors orchestrate ataxia telangiectasia-mutated and Rad3-related protein–autophagy related 13-dependent mitophagy to clear reactive oxygen species-damaged mitochondria, maintaining metabolic efficiency during energy stress. Targeted metabolomics, Seahorse flux, and molecular pathological analysis revealed NMDA receptor-dependent remodeling of glucose metabolism, tricarboxylic acid cycle, nucleotide synthesis, and mitochondrial ultrastructure in SC. NMDA receptor deficiency disrupts energy metabolism and impairs axonal survival following sciatic nerve injury, resulting in aggravated neurological deficits and hindered nerve regeneration. Crucially, NMDA receptor activation rescued axonal integrity and motor function in mice with acute motor axonal neuropathy, underscoring their therapeutic potential. Our findings establish NMDA receptors as dual regulators of SC energy metabolism and mitochondrial quality control, providing a novel strategy to enhance glia-axonal metabolic coupling in peripheral neuropathies.
- 16 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8
Open AccessNMDA Receptors Coordinate Metabolic Reprogramming and Mitophagy in Schwann Cells to Promote Peripheral Nerve Regeneration
Schwann cells (SCs) are indispensable for peripheral nerve regeneration, yet the mechanisms enabling their metabolic adaptation to meet the energetic demands of axonal repair remain elusive. Here, we identify N-methyl-D-aspartate (NMDA) receptors as central regulators of SC metabolic plasticity. In a mouse model of acute motor axonal neuropathy, nerve injury led to a marked decrease in NMDA receptor expression on SC. Functional studies revealed that NMDA receptors mediate calcium influx to drive glycolysis and oxidative phosphorylation via the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin and hypoxia-inducible factor-1α/c-Myc pathways, ensuring adenosine triphosphate production for axonal repair. Simultaneously, NMDA receptors orchestrate ataxia telangiectasia-mutated and Rad3-related protein–autophagy related 13-dependent mitophagy to clear reactive oxygen species-damaged mitochondria, maintaining metabolic efficiency during energy stress. Targeted metabolomics, Seahorse flux, and molecular pathological analysis revealed NMDA receptor-dependent remodeling of glucose metabolism, tricarboxylic acid cycle, nucleotide synthesis, and mitochondrial ultrastructure in SC. NMDA receptor deficiency disrupts energy metabolism and impairs axonal survival following sciatic nerve injury, resulting in aggravated neurological deficits and hindered nerve regeneration. Crucially, NMDA receptor activation rescued axonal integrity and motor function in mice with acute motor axonal neuropathy, underscoring their therapeutic potential. Our findings establish NMDA receptors as dual regulators of SC energy metabolism and mitochondrial quality control, providing a novel strategy to enhance glia-axonal metabolic coupling in peripheral neuropathies.
- Open Access
The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice
- 1 January 2022
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 366, 109404
A fast and efficient method for isolating Schwann cells from sciatic nerves of neonatal mice
- 1 January 2022
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 366, 109404
A fast and efficient method for isolating Schwann cells from sciatic nerves of neonatal mice
- 1 June 2021
- Published by Elsevier in Journal of Infection
- Vol. 82 (6) , 276-316
Comparison of the role of neutrophil extracellular traps between patients admitted to the intensive care unit with influenza A and B virus infection
- 1 June 2021
- Published by Elsevier in Journal of Infection
- Vol. 82 (6) , 276-316
Comparison of the role of neutrophil extracellular traps between patients admitted to the intensive care unit with influenza A and B virus infection
- 21 October 2020
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 15 (1) , 41-44
Resonance assignments of La protein RRM domain from Trypanosoma brucei
The autoantigen La protein is a conserved component of eukaryotic ribonucleoprotein complexes that binds the 3′ poly(U) sequences of nascent RNA polymerase III transcripts to assist folding and maturation. This specific recognition is mediated by the N-terminal domain (NTD) of La, which comprises a La motif and an RNA recognition motif (RRM). Here, we report near complete 1H, 13C and 15N backbone and sidechain assignments for the RRM domain of La protein from Trypanosoma brucei.
- 21 October 2020
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 15 (1) , 41-44
Resonance assignments of La protein RRM domain from Trypanosoma brucei
The autoantigen La protein is a conserved component of eukaryotic ribonucleoprotein complexes that binds the 3′ poly(U) sequences of nascent RNA polymerase III transcripts to assist folding and maturation. This specific recognition is mediated by the N-terminal domain (NTD) of La, which comprises a La motif and an RNA recognition motif (RRM). Here, we report near complete 1H, 13C and 15N backbone and sidechain assignments for the RRM domain of La protein from Trypanosoma brucei.